|
|
Effect of Remifentanil combined with Propofol on painless gastroscopy anesthesia |
HAN Lei |
Department of Anesthesiology, Beijing Hospital of Integrated Traditional Chinese and Western Medicine, Beijing 100039, China |
|
|
Abstract Objective To observe the clinical effect of Remifentanil combined with Propofol on painless gastroscopy anesthesia. Methods A total of 100 patients who underwent painless gastroenteroscopy and treatment in our hospital from October 2017 to August 2018 were selected. According to the random numer table method, they were divided into two groups with 50 patients in each group. Group A (experimental group) was anesthetized with Remifentanil 0.3-0.5 μg/kg combined with Propofol. Group B (control group) was given Propofol 1.5-2.0 mg/kg to complete the operation. The mean arterial pressure, heart rate, Propofol dosage, gastroenteroscopy time, waking time, anesthetic effect, and adverse reactions of the two groups were observed and compared. Results There were no significant differences in mean arterial pressure and heart rate between the two groups (P>0.05). Propofol dosage in group A was less than that in group B,with statistically significant difference(P<0.05).The recovery time of patients in group A was shorter than that in group B,the difference was statistically significant (P<0.05). There was no significant difference between the two groups in gastrointestinal endoscopy and the time of patients leaving hospital after awake (P>0.05). The excellent rate of anesthesia effect in group A was higher than that in group B, the difference was statistically significant (P<0.05). The occurrence rate of respiratory depression in group A was lower than that in group B, the difference was statistically significant (P<0.05). There was no significant difference in the occurrence rate of postoperative nausea, vomiting, vertigo between the two groups (P>0.05). Conclusion Remifentanil combined with Propofol for painless gastrointestinal endoscopy anesthesia reduces the dosage of Propofol, shortens the recovery time of patients, has fewer adverse reactions, and is safe and effective in clinical use.
|
|
|
|
|
[1] |
张丽,张莉娜,朱娇,等.情绪引导对胃镜检查前不良情绪及疼痛度的改善研究[J].现代消化及介入诊疗,2016,26(6):930-932.
|
[2] |
吕亚丽.丙泊酚用于无痛胃肠镜的镇痛效果评定及安全性分析[J].河北医学,2019,25(6):979-982.
|
[3] |
周春兰,王超,王兰,等.不同剂量羟考酮复合依托咪酯用于老年患者无痛胃镜检查的效果[J].临床麻醉学杂志,2019,35(4):377-379.
|
[4] |
殷勇,吴志浩.无痛胃肠镜麻醉药物的选择及应用效果分析[J].中国继续医学教育,2019,11(11):86-89.
|
[5] |
李清春,李洪军,梁筠.胃肠疾病筛查平台在健康体检中的应用[J].广西医学,2019,41(9):1200-1202,1205.
|
[6] |
邵丹丹,王红晓,闵军霞,等.膳食因素与消化道肿瘤关系的研究进展[J].基因组学与应用生物学,2016,35(5):1101-1107.
|
[7] |
张炜,陈长旦,郑秀金.消化内镜对消化道肿瘤患者的早期诊断治疗[J].医疗装备,2018,18(15):23-24.
|
[8] |
唐曙华,斯妍娜,鲍红光,等.丙泊酚复合纳布啡对无痛肠镜检查患者膈肌运动的影响[J].临床麻醉学杂志,2019,36(1):42-46.
|
[9] |
孙辛欣,朱涛.麻醉在胃肠镜检查中应用的研究进展[J].国际消化病杂志,2015,39(3):215-216.
|
[10] |
李琴,陈春生.无痛胃肠镜早癌精查诊疗过程不良反应分析及护理措施[J].中国实用医药,2019,14(5):166-167.
|
[11] |
马贵阳.无痛胃肠镜与常规胃肠镜在消化道疾病中的临床应用[J].中国当代医药,2017,29(3):30-32.
|
[12] |
王晓阁.丙泊酚临床应用进展[J].天津药学,2019,31(1):67-70.
|
[13] |
曾凤华,王云,肖兴鹏.丙泊酚用于无痛胃镜检查术中纳布啡最佳剂量的选择[J].临床外科杂志,2019,27(6):520-522.
|
[14] |
贾姿.瑞芬太尼麻醉在手术患者中的应用分析[J].中国医药指南,2019,17(1):100-101.
|
[15] |
黄文杰,李中东.芬太尼及其类似物的研究概述[J].中国临床神经科学,2019,27(4):443-449.
|
|
|
|